Alembic Pharmaceuticals to Hold Board Meeting on May 15 to Discuss FY2026 Results and Dividend
Alembic Pharmaceuticals Ltd announced that its Board of Directors will convene a meeting on Friday, May 15, 2026. The primary purpose of the meeting is to review and consider the audited financial results of the company for the quarter and the full financial year ended March 31, 2026.During the session, the board is scheduled to address two main items. First, it will consider and approve the audited financial results for the quarter and the entire financial year that closed on March 31, 2026. Second, the directors will consider and recommend any dividend on the equity shares for the financial year ending March 31, 2026.
The company also provided an update regarding trading activities. The trading window for dealing in the securities of Alembic Pharmaceuticals, which had been closed since April 1, 2026, is set to reopen 48 hours following the declaration of the financial results.
APLLTD Stock Price Movement
Shares of Alembic Pharmaceuticals Limited are edging higher to ₹768.3 as of 1:33 PM today, jumping 2.30% in live trading. The equity is currently active on a volume of 126,150 shares, remaining well within its day's range established between ₹762.6 and ₹795.95.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.